Guideline-concordant lung cancer care and associated health outcomes among elderly patients in the United States

Journal of Geriatric Oncology

Volumn 6, Issue 2, 2015, Pages 101-110

  Nadpara, Pramit A ^a   Madhavan, S Suresh ^b   Tworek, Cindy ^b   Sambamoorthi, Usha ^b   Hendryx, Michael ^c   Almubarak, Mohammed ^d  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

^c INDIANA UNIVERSITY   (United States)

^d WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer; Disparities; Elderly; Guidelines; Lung; Medicare; Treatment

Indexed keywords

AGE DISTRIBUTION; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; EVIDENCE BASED PRACTICE; FEMALE; GUIDELINE CONCORDANT LUNG CANCER CARE; HEALTH CARE DISPARITY; HUMAN; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; NON SMALL CELL LUNG CANCER; PATIENT IDENTIFICATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RACE DIFFERENCE; SMALL CELL LUNG CANCER; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; UNITED STATES; URBAN RURAL DIFFERENCE; VERY ELDERLY; CANCER REGISTRY; EVIDENCE BASED MEDICINE; KAPLAN MEIER METHOD; LUNG NEOPLASMS; MORTALITY; OUTCOME ASSESSMENT; PROPORTIONAL HAZARDS MODEL; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA;

AGED; AGED, 80 AND OVER; EVIDENCE-BASED MEDICINE; FEMALE; GUIDELINE ADHERENCE; HEALTHCARE DISPARITIES; HUMANS; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; LUNG NEOPLASMS; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PRACTICE GUIDELINES AS TOPIC; PROPORTIONAL HAZARDS MODELS; SEER PROGRAM; UNITED STATES;

EID: 84925260676     PISSN: 18794068     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jgo.2015.01.001     Document Type: Article

References (30)

1. U.S.National Institutes of Health National Cancer Institute: SEER Cancer Statistics Review, 1973-2008 Available at, [Accessed on: October 1, 2014]. http://seer.cancer.gov/csr/1975_2009_pops09/index.html.
2. Day J.C. Population Projections of the United States by Age, Sex, Race, and Hispanic Origin: 1995-2050. US Bureau of the Census, Current Population Reports, Washington, DC 1996, 25-1130.
3. Pfister D.G., Johnson D.H., Azzoli C.G., Sause W., Smith T.J., Baker S., et al. American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003. J Clin Oncol January 15 2004, 22(2):330-353.
4. Diagnosis and management of lung cancer: ACCP evidence-based guidelines. American College of Chest Physicians. Chest January 2003, 123(1 Suppl):D-337S.
5. Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. Adopted on May 16, 1997 by the American Society of Clinical Oncology. J Clin Oncol August 1997, 15(8):2996-3018.
6. National Comprehensive Cancer Network and American Cancer Society: Lung Cancer: Treatment Guidelines for Patients. Version 1 Available at, [Accessed on: October 1, 2014]. http://www.nccn.org.
7. National Cancer Institute: Physician Data Query Cancer Information Summaries Available at, [Accessed on: October 1, 2014]. http://www.nci.nih.gov/cancerinfo/pdf/treatment/non-small-cell-lung/healthprofessional/.
8. Pallis A.G., Gridelli C., Wedding U., Faivre-Finn C., Veronesi G., Jaklitsch M., et al. Management of elderly patients with NSCLC; updated expert's opinion paper: EORTC Elderly Task Force, Lung Cancer Group and International Society for Geriatric Oncology. Ann Oncol July 2014, 25(7):1270-1283.
9. Institute of Medicine Committee to Advise the Public Health Service on Clinical Practice Guidelines. Clinial practice guidelines: directions for a new program 1990, National Academy Press, Washington, DC. M. Field, K. Lohr (Eds.).
10. Bradley C.J., Dahman B., Given C.W. Treatment and survival differences in older Medicare patients with lung cancer as compared with those who are dually eligible for Medicare and Medicaid. J Clin Oncol November 1 2008, 26(31):5067-5073.
11. Potosky A.L., Saxman S., Wallace R.B., Lynch C.F. Population variations in the initial treatment of non-small-cell lung cancer. J Clin Oncol August 15 2004, 22(16):3261-3268.
12. Earle C.C., Venditti L.N., Neumann P.J., Gelber R.D., Weinstein M.C., Potosky A.L., et al. Who gets chemotherapy for metastatic lung cancer?. Chest May 2000, 117(5):1239-1246.
13. Fry W.A., Phillips J.L., Menck H.R. Ten-year survey of lung cancer treatment and survival in hospitals in the United States: a national cancer data base report. Cancer November 1 1999, 86(9):1867-1876.
14. Bach P.B., Cramer L.D., Warren J.L., Begg C.B. Racial differences in the treatment of early-stage lung cancer. N Engl J Med October 14 1999, 341(16):1198-1205.
15. Hillner B.E., McDonald M.K., Desch C.E., Smith T.J., Penberthy L.T., Retchin S.M. A comparison of patterns of care of nonsmall cell lung carcinoma patients in a younger and Medigap commercially insured cohort. Cancer November 1 1998, 83(9):1930-1937.
16. Smith T.J., Penberthy L., Desch C.E., Whittemore M., Newschaffer C., Hillner B.E., et al. Differences in initial treatment patterns and outcomes of lung cancer in the elderly. Lung Cancer December 1995, 13(3):235-252.
17. Slatore C.G., Au D.H., Gould M.K. An official American Thoracic Society systematic review: insurance status and disparities in lung cancer practices and outcomes. Am J Respir Crit Care Med November 1 2010, 182(9):1195-1205.
18. Salloum R.G., Smith T.J., Jensen G.A., Lafata J.E. Factors associated with adherence to chemotherapy guidelines in patients with non-small cell lung cancer. Lung Cancer February 2012, 75(2):255-260.
19. Landrum M.B., Keating N.L., Lamont E.B., Bozeman S.R., McNeil B.J. Reasons for underuse of recommended therapies for colorectal and lung cancer in the Veterans Health Administration. Cancer July 1 2012, 118(13):3345-3355.
20. Zornosa C., Vandergrift J.L., Kalemkerian G.P., Ettinger D.S., Rabin M.S., Reid M., et al. First-line systemic therapy practice patterns and concordance with NCCN guidelines for patients diagnosed with metastatic NSCLC treated at NCCN institutions. J Natl Compr Canc Netw July 1 2012, 10(7):847-856.
21. Lee J.Y., Moore P.C., Steliga M.A. Do HIV-infected non-small cell lung cancer patients receive guidance-concordant care?. Med Care December 2013, 51(12):1063-1068.
22. Ensuring the Quality of Cancer Care 1999, National Academy Press, Washington, DC. M. Hewitt, J.V. Simone (Eds.).
23. Warren J.L., Klabunde C.N., Schrag D., Bach P.B., Riley G.F. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care August 2002, 40(8 Suppl). [IV-18].
24. Mountain C.F. Revisions in the International System for Staging Lung Cancer. Chest June 1997, 111(6):1710-1717.
25. Agreement between the SEER & Medicare claims regarding the month of diagnosis Available at, [Accessed on: October 1, 2014]. http://healthservices.cancer.gov/seermedicare/considerations/date.html.
26. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40(5):373-383.
27. Deyo R.A., Cherkin D.C., Ciol M.A. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol June 1992, 45(6):613-619.
28. Romano P.S., Roos L.L., Jollis J.G. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol October 1993, 46(10):1075-1079.
29. Lin D.Y., Wei L.J. The robust inference for the Cox Proportional Hazards Model. J Am Stat Assoc December 1989, 84(408):1074-1078.
30. Potosky A.L., Riley G.F., Lubitz J.D., Mentnech R.M., Kessler L.G. Potential for cancer related health services research using a linked Medicare-tumor registry database. Med Care August 1993, 31(8):732-748.